Recruiting Pulmonary Embolism Studies in Littleton
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH ...
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic s...
About Pulmonary Embolism Clinical Trials in Littleton
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Littleton, COLORADO. These studies are seeking a combined 210 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Littleton — FAQ
Are there pulmonary embolism clinical trials in Littleton?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Littleton, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Littleton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Littleton research site will contact you about next steps.
Are clinical trials in Littleton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Littleton studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Littleton are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov